Verastem Oncology Reports First Quarter 2019 Financial Results
Company Reports $1.7 Million in Net Product Revenues from COPIKTRA™; Issues Product Revenue Guidance for 2019 Cash, Cash Equivalents and…
Pharmaceuticals, Biotechnology and Life Sciences
Company Reports $1.7 Million in Net Product Revenues from COPIKTRA™; Issues Product Revenue Guidance for 2019 Cash, Cash Equivalents and…
– Company will host a conference call and webcast at 5:00 pm ET today – CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24SYBX&src=ctag" target="_blank"gt;$SYBXlt;/agt;…
– Conference Call Today at 4:30 p.m. ET – SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to…
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular…
– $13 million raised in 1H19 – – Norovirus bivalent vaccine Phase 1b clinical study underway with results expected in…
64% Q1 revenue growth and 650 bps gross margin improvement LEXINGTON, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis…
Topline results in the previously treated EGFR cohort (cohort 1) of the poziotinib ZENITH20 trial are expected in Q4 2019.…
DUBLIN–(BUSINESS WIRE)–The “Global Bone Cancer Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. Small and medium sized pharmaceutical…
Due to an increase in the incidence of medical ailments, the marketstudied is expected to grow over the forecast period.
Second Launch@Shares Competition Announced in Collaboration withMTTC/MALSI Conference and MassBio’s MassCONNECT Program